Company: GIFLF
Filing Date: 2025-02-26
Form Type: 6-K
Source: 0001104659-25-017501
Chunk: 7

Company: Grifols SA
Filing Date: 2025-02-26
Form: 6-K
Chunk 7
---
) contain, in addition to the financial info rma tion prepared in accordance with IFRS, alternative performance measures (‘APMs’) as defined in the guidelines issued by the European Securities and Markets Authority (‘ESMA’) on October 5, 2015. APMs are used by Grifols’ management to evaluate the group’s financial performance, cash flows or financial position in making operational and strategic decisions for the group and therefore are useful information for inves tor s and other stakeholders. Certain key APMs form part of executive directors, management and employees’ remuneration targets. APMs are prepared on a consistent basis for the periods presented in this document. They should be considered in addition to IFR S measurements, may differ to definitions given by regulatory bodies relevant to the group and to similarly titled measures presented by other companies. They have not been audited, reviewed or verified by the ext ernal auditor of Grifols. For further details on the definition, explanation on the use, and reconciliation of APMs, please see the appendix as well as the “Alternative performance measures” document from our websi te www.grifols.com/en/investors . Basis of Presentation For comparative purposes with YTD Q4'24, the financial statements for Q4’23 have been re - expressed according to the Inside Infor mation released on July 30, 2024, and further disclosed in accordance with Note 2(d) of the Consolidated Interim Financial Statements for FY’24.

- 3 - Q4 2024 Results 01 02 03 04 Introductory Remarks Business Performance Financials Final Remarks Annex 05 Agenda Nacho Abia Chief Executive Officer (CEO) Rahul Srinivasan Chief Financial Officer (CFO)

- 4 - Q4 2024 Results Nacho Abia Chief Executive Officer (CEO) Delivered a Record 2024 with Strong Performance and Strategic Execution

- 5 - Q4 2024 Results Introductory Remarks Business Performance Financials Final remarks Annex Opening Remarks Challenging Year Faced with Strategic Execution and Delivery Business performance • Robust performance exceeding revenue and FCF guidance • Q4 and FY2024 revenues and adj. EBITDA reach new all - time highs • Solid business momentum driven by strong underlying demand • Optimized plasma capabilities and increased efficiencies • Achieved 2024 innovation milestones Balance sheet • Organic sequential deleveraging through the year • Strengthened balance sheet through SRAAS asset sale and